Hypertension · 2023 · 14 citations · 12 references
MedicineCardiologyPreventive MedicinePreventive CardiologyRisk AnalysisRisk AssessmentAtherosclerotic Cardiovascular Disease PreventionCardiac Risk AssessmentCardiovascular DiseaseCardiovascular Disease PreventionCardiovascular EpidemiologyCardiovascular RiskAtherosclerosis RiskAtherosclerotic Cardiovascular Disease Risk EstimationAtherosclerotic Disease PreventionAtherosclerotic Risk AssessmentDeath RatesHazard Ratio InterpretationHazard Ratio ModelingPrimary Prevention Risk Assessment
BACKGROUND: Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate (∆10-year ASCVD risk/year) are unknown. METHODS: A total of 211 077 participants without established ASCVD and with repetitive 10-year ASCVD risk assessment at an interval of 4 to 5 years were selected from the Korean National Health Insurance Service data. The primary end point was a composite of myocardial infarction, stroke, coronary revascularization, and all-cause death. RESULTS: ASCVD event rates were proportional to the ∆10-year ASCVD risk/year regardless of the baseline 10-year ASCVD risk. Adjusted hazard ratio for ASCVD events per 1% increase in ∆10-year ASCVD risk/year was 1.53 (95% CI, 1.44-1.63), 1.24 (95% CI, 1.15-1.32), 1.18 (95% CI, 1.13-1.23), and 1.05 (95% CI, 1.00-1.10) in those with a baseline 10-year ASCVD risk of <5%, 5% to 7.5%, 7.5% to 20%, and ≥20%, respectively. Appropriate control of risk factors, including low-density lipoprotein cholesterol, blood pressure, body mass index, exercise habits, and smoking status, was associated with lower ASCVD event rates, whereas failure to control these risk factors resulted in higher ASCVD event rates. CONCLUSIONS: The temporal change in 10-year ASCVD risk over a period of 4 to 5 years reflects success or failure in controlling major cardiovascular risk factors and indicates the risk of future ASCVD events. The ∆10-year ASCVD risk/year can be used as an indicator of primary prevention and guide the application of preventive measures.
12
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders et al. · European Heart Journal · 2021 · 6.3K citations · Full text
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett et al. · Circulation · 2013 · 3.7K citations · Full text
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population
Xueli Yang, Jianxin Li, Dongsheng Hu et al. · Circulation · 2016 · 661 citations · Full text
Medicine, Cardiology, Epidemiology +16
Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
Paul Muntner, Lisandro D. Colantonio, Mary Cushman et al. · JAMA · 2014 · 617 citations
Medicine, Biostatistics, Cardiology +17